QHSLab, Inc. (USAQ)
USD 0.18
(-9.72%)
USD 0.18
(-9.72%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.05 Million USD | 9.35% |
| 2022 | 1.88 Million USD | 35.88% |
| 2021 | 1.38 Million USD | 52.78% |
| 2020 | 906.18 Thousand USD | 98.67% |
| 2019 | 456.13 Thousand USD | -14.78% |
| 2018 | 535.26 Thousand USD | 8.16% |
| 2017 | 494.88 Thousand USD | 2.35% |
| 2016 | 483.52 Thousand USD | 5.05% |
| 2015 | 460.28 Thousand USD | 11.4% |
| 2014 | 413.16 Thousand USD | 10.86% |
| 2013 | 372.69 Thousand USD | 23.07% |
| 2012 | 302.82 Thousand USD | 29.85% |
| 2011 | 233.2 Thousand USD | 49.31% |
| 2010 | 156.18 Thousand USD | 67.23% |
| 2009 | 93.39 Thousand USD | 85.1% |
| 2008 | 50.45 Thousand USD | 282.65% |
| 2007 | 13.18 Thousand USD | 0.0% |
| 2006 | 13.18 Thousand USD | 152.56% |
| 2005 | 5221.00 USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | -100.0% |
| 2001 | 712 Thousand USD | 10.22% |
| 2000 | 646 Thousand USD | -72.63% |
| 1999 | 2.36 Million USD | 156.52% |
| 1998 | 920 Thousand USD | -66.05% |
| 1997 | 2.71 Million USD | -75.21% |
| 1996 | 10.93 Million USD | 30.43% |
| 1995 | 8.38 Million USD | 1943.9% |
| 1994 | 410 Thousand USD | -51.76% |
| 1993 | 850 Thousand USD | 77.08% |
| 1992 | 480 Thousand USD | 45.45% |
| 1991 | 330 Thousand USD | -77.85% |
| 1990 | 1.49 Million USD | -59.84% |
| 1989 | 3.71 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 2.11 Million USD | 2.73% |
| 2024 Q2 | 2.08 Million USD | -1.42% |
| 2023 FY | 2.05 Million USD | 9.35% |
| 2023 Q1 | 1.95 Million USD | 3.76% |
| 2023 Q3 | 2.03 Million USD | -1.3% |
| 2023 Q4 | 2.05 Million USD | 0.91% |
| 2023 Q2 | 2.06 Million USD | 5.81% |
| 2022 FY | 1.88 Million USD | 35.88% |
| 2022 Q1 | 1.5 Million USD | 8.52% |
| 2022 Q2 | 1.62 Million USD | 8.4% |
| 2022 Q3 | 1.86 Million USD | 14.56% |
| 2022 Q4 | 1.88 Million USD | 0.83% |
| 2021 Q2 | 1.43 Million USD | 117.75% |
| 2021 Q3 | 1.86 Million USD | 29.93% |
| 2021 Q1 | 660.96 Thousand USD | -27.06% |
| 2021 Q4 | 1.38 Million USD | -25.97% |
| 2021 FY | 1.38 Million USD | 52.78% |
| 2020 Q3 | 643.69 Thousand USD | 18.54% |
| 2020 Q2 | 543.02 Thousand USD | 6.58% |
| 2020 FY | 906.18 Thousand USD | 98.67% |
| 2020 Q1 | 509.48 Thousand USD | 11.7% |
| 2020 Q4 | 906.18 Thousand USD | 40.78% |
| 2019 FY | 456.13 Thousand USD | -14.78% |
| 2019 Q2 | 555.99 Thousand USD | 1.55% |
| 2019 Q4 | 456.13 Thousand USD | 53.71% |
| 2019 Q3 | 296.74 Thousand USD | -46.63% |
| 2019 Q1 | 547.48 Thousand USD | 2.28% |
| 2018 FY | 535.26 Thousand USD | 8.16% |
| 2018 Q2 | 518.61 Thousand USD | 4.21% |
| 2018 Q3 | 530.66 Thousand USD | 2.32% |
| 2018 Q1 | 497.65 Thousand USD | 0.56% |
| 2018 Q4 | 535.26 Thousand USD | 0.87% |
| 2017 Q2 | 489.21 Thousand USD | 0.58% |
| 2017 FY | 494.88 Thousand USD | 2.35% |
| 2017 Q3 | 492.04 Thousand USD | 0.58% |
| 2017 Q4 | 494.88 Thousand USD | 0.58% |
| 2017 Q1 | 486.4 Thousand USD | 0.6% |
| 2016 FY | 483.52 Thousand USD | 5.05% |
| 2016 Q1 | 473.87 Thousand USD | 2.95% |
| 2016 Q2 | 476.76 Thousand USD | 0.61% |
| 2016 Q3 | 480.39 Thousand USD | 0.76% |
| 2016 Q4 | 483.52 Thousand USD | 0.65% |
| 2015 Q3 | 449.74 Thousand USD | 2.77% |
| 2015 FY | 460.28 Thousand USD | 11.4% |
| 2015 Q2 | 437.63 Thousand USD | 3.28% |
| 2015 Q1 | 423.74 Thousand USD | 2.56% |
| 2015 Q4 | 460.28 Thousand USD | 2.34% |
| 2014 Q3 | 401.58 Thousand USD | 2.23% |
| 2014 Q4 | 413.16 Thousand USD | 2.88% |
| 2014 Q1 | 383.01 Thousand USD | 2.77% |
| 2014 FY | 413.16 Thousand USD | 10.86% |
| 2014 Q2 | 392.8 Thousand USD | 2.56% |
| 2013 Q3 | 355.66 Thousand USD | 5.03% |
| 2013 Q1 | 321.6 Thousand USD | 6.2% |
| 2013 FY | 372.69 Thousand USD | 23.07% |
| 2013 Q4 | 372.69 Thousand USD | 4.79% |
| 2013 Q2 | 338.63 Thousand USD | 5.3% |
| 2012 Q2 | 268.76 Thousand USD | 6.66% |
| 2012 Q3 | 285.79 Thousand USD | 6.34% |
| 2012 Q4 | 302.82 Thousand USD | 5.96% |
| 2012 FY | 302.82 Thousand USD | 29.85% |
| 2012 Q1 | 251.98 Thousand USD | 8.05% |
| 2011 FY | 233.2 Thousand USD | 49.31% |
| 2011 Q4 | 233.2 Thousand USD | 7.75% |
| 2011 Q2 | 199.64 Thousand USD | 9.95% |
| 2011 Q1 | 181.56 Thousand USD | 16.25% |
| 2011 Q3 | 216.42 Thousand USD | 8.41% |
| 2010 FY | 156.18 Thousand USD | 67.23% |
| 2010 Q1 | 107.17 Thousand USD | 14.75% |
| 2010 Q2 | 118.95 Thousand USD | 10.99% |
| 2010 Q3 | 136.76 Thousand USD | 14.97% |
| 2010 Q4 | 156.18 Thousand USD | 14.2% |
| 2009 FY | 93.39 Thousand USD | 85.1% |
| 2009 Q3 | 81.6 Thousand USD | 14.0% |
| 2009 Q2 | 71.58 Thousand USD | 15.47% |
| 2009 Q4 | 93.39 Thousand USD | 14.45% |
| 2009 Q1 | 61.99 Thousand USD | 22.86% |
| 2008 Q2 | 31.41 Thousand USD | 29.89% |
| 2008 Q1 | 24.18 Thousand USD | 83.42% |
| 2008 Q3 | 40.95 Thousand USD | 30.37% |
| 2008 FY | 50.45 Thousand USD | 282.65% |
| 2008 Q4 | 50.45 Thousand USD | 23.2% |
| 2007 Q2 | 25.18 Thousand USD | 31.27% |
| 2007 Q4 | 13.18 Thousand USD | -48.66% |
| 2007 Q1 | 19.18 Thousand USD | 45.5% |
| 2007 FY | 13.18 Thousand USD | 0.0% |
| 2007 Q3 | 25.68 Thousand USD | 1.99% |
| 2006 Q3 | 7186.00 USD | 505.9% |
| 2006 FY | 13.18 Thousand USD | 152.56% |
| 2006 Q1 | 586.00 USD | -94.14% |
| 2006 Q2 | 1186.00 USD | 102.39% |
| 2006 Q4 | 13.18 Thousand USD | 83.5% |
| 2005 Q4 | 10 Thousand USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 FY | 5221.00 USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2002 Q3 | - USD | -100.0% |
| 2002 Q4 | - USD | 0.0% |
| 2002 Q1 | 873 Thousand USD | 22.61% |
| 2002 FY | - USD | -100.0% |
| 2002 Q2 | 1.07 Million USD | 23.14% |
| 2001 Q3 | 670 Thousand USD | -47.37% |
| 2001 Q4 | 712 Thousand USD | 6.27% |
| 2001 Q1 | 747 Thousand USD | 15.63% |
| 2001 Q2 | 1.27 Million USD | 70.41% |
| 2001 FY | 712 Thousand USD | 10.22% |
| 2000 FY | 646 Thousand USD | -72.63% |
| 2000 Q4 | 646 Thousand USD | 30.24% |
| 2000 Q3 | 496 Thousand USD | -20.0% |
| 2000 Q2 | 620 Thousand USD | -27.49% |
| 2000 Q1 | 855 Thousand USD | -63.77% |
| 1999 Q4 | 2.36 Million USD | 84.38% |
| 1999 FY | 2.36 Million USD | 156.52% |
| 1999 Q2 | 860 Thousand USD | 7.5% |
| 1999 Q3 | 1.28 Million USD | 48.84% |
| 1999 Q1 | 800 Thousand USD | -13.04% |
| 1998 Q2 | 5.18 Million USD | 169.79% |
| 1998 Q3 | 4.73 Million USD | -8.69% |
| 1998 Q4 | 920 Thousand USD | -80.55% |
| 1998 FY | 920 Thousand USD | -66.05% |
| 1998 Q1 | 1.92 Million USD | -29.15% |
| 1997 Q3 | 3.14 Million USD | 6.44% |
| 1997 Q4 | 2.71 Million USD | -13.69% |
| 1997 FY | 2.71 Million USD | -75.21% |
| 1997 Q1 | 7.59 Million USD | -30.56% |
| 1997 Q2 | 2.95 Million USD | -61.13% |
| 1996 Q3 | 11.53 Million USD | 348.64% |
| 1996 FY | 10.93 Million USD | 30.43% |
| 1996 Q1 | 3 Million USD | -64.2% |
| 1996 Q2 | 2.57 Million USD | -14.33% |
| 1996 Q4 | 10.93 Million USD | -5.2% |
| 1995 Q4 | 8.38 Million USD | 1804.55% |
| 1995 Q1 | 440 Thousand USD | 7.32% |
| 1995 Q2 | 490 Thousand USD | 11.36% |
| 1995 Q3 | 440 Thousand USD | -10.2% |
| 1995 FY | 8.38 Million USD | 1943.9% |
| 1994 Q3 | 430 Thousand USD | -25.86% |
| 1994 Q1 | 630 Thousand USD | -25.88% |
| 1994 Q2 | 580 Thousand USD | -7.94% |
| 1994 Q4 | 410 Thousand USD | -4.65% |
| 1994 FY | 410 Thousand USD | -51.76% |
| 1993 Q1 | 450 Thousand USD | -6.25% |
| 1993 Q4 | 850 Thousand USD | 54.55% |
| 1993 Q2 | 820 Thousand USD | 82.22% |
| 1993 Q3 | 550 Thousand USD | -32.93% |
| 1993 FY | 850 Thousand USD | 77.08% |
| 1992 Q3 | 570 Thousand USD | 29.55% |
| 1992 Q4 | 480 Thousand USD | -15.79% |
| 1992 Q2 | 440 Thousand USD | 2.33% |
| 1992 Q1 | 430 Thousand USD | 30.3% |
| 1992 FY | 480 Thousand USD | 45.45% |
| 1991 Q4 | 330 Thousand USD | -80.0% |
| 1991 Q3 | 1.65 Million USD | 0.0% |
| 1991 FY | 330 Thousand USD | -77.85% |
| 1991 Q1 | 1.48 Million USD | -0.67% |
| 1990 Q3 | 1.61 Million USD | 0.0% |
| 1990 Q4 | 1.49 Million USD | -7.45% |
| 1990 FY | 1.49 Million USD | -59.84% |
| 1989 FY | 3.71 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AVITA Medical, Inc. | 19.86 Million USD | 89.645% |
| Manhattan Scientifics, Inc. | 2.11 Million USD | 2.878% |
| Össur hf. | 688.8 Million USD | 99.701% |
| Wellstar International, Inc. | 55.99 Million USD | 96.326% |
| Össur hf. | 688.8 Million USD | 99.701% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 2.94 Million USD | 30.23% |
| Aurora Spine Corporation | 6.65 Million USD | 69.083% |
| BrainsWay Ltd. | 15.31 Million USD | 86.568% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 16.62 Million USD | 87.625% |
| Hamilton Thorne Ltd. | 45.84 Million USD | 95.513% |
| Vivos Inc. | 245 Thousand USD | -739.598% |
| Kelyniam Global, Inc. | 1.01 Million USD | -103.078% |
| REMSleep Holdings, Inc. | 275.61 Thousand USD | -646.351% |
| Zecotek Photonics Inc. | 5.86 Million USD | 64.948% |
| Avitar, Inc. | 11.59 Million USD | 82.257% |
| Nanomix Corporation | 14.81 Million USD | 86.115% |
| EKF Diagnostics Holdings plc | 16.08 Million USD | 87.208% |
| Theraclion SA | 13.01 Million EUR | 84.197% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | 2.02 Million USD | -1.533% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.62 Million USD | 43.194% |
| Lombard Medical, Inc. | 53.79 Million USD | 96.176% |
| ALR Technologies Inc. | 24.5 Million USD | 91.606% |
| Stratec SE | 271.97 Million USD | 99.244% |
| Vycor Medical, Inc. | 4.31 Million USD | 52.359% |
| Heart Tronics, Inc. | 1.09 Million USD | -87.895% |
| MicroPort Scientific Corporation | 2.48 Billion USD | 99.917% |
| VMS Rehab Systems, Inc. | 201.36 USD | -1021477.771% |
| NewCardio, Inc. | 6.01 Million USD | 65.788% |
| Guided Therapeutics, Inc. | 5.47 Million USD | 62.428% |
| Ingen Technologies, Inc. | 5.7 Million USD | 63.972% |
| Odyssey Group International, Inc. | 6.61 Million USD | 68.888% |
| CYduct Diagnostics, Inc. | 2.44 Million USD | 16.032% |
| Wellness Center USA, Inc. | 5.12 Million USD | 59.856% |
| SANUWAVE Health, Inc. | 65.59 Million USD | 96.864% |
| IR-Med Inc. | 634 Thousand USD | -224.456% |
| Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | 62.439% |
| Polarean Imaging plc | 2.58 Million USD | 20.286% |
| United American Healthcare Corporation | 119 Thousand USD | -1628.613% |
| ECGI Holdings, Inc. | 11.94 Million USD | 82.772% |
| Nu-Med Plus, Inc. | 2.35 Million USD | 12.792% |
| Capital Group Holdings, Inc. | 1.32 Million USD | -55.368% |
| ADM Tronics Unlimited, Inc. | 1.44 Million USD | -42.225% |
| Medical Supply International USA, Inc. | 677.61 Thousand USD | -203.571% |
| Urologix, Inc. | 12.64 Million USD | 83.731% |
| Rapid Therapeutic Science Laboratories, Inc. | 5.39 Million USD | 61.879% |
| Nexeon MedSystems Inc. | 8.48 Million USD | 75.749% |
| SS Innovations International, Inc. | 11.18 Million USD | 81.602% |
| Qualis Innovations, Inc. | 525.38 Thousand USD | -291.53% |
| Smith & Nephew plc | 4.76 Billion USD | 99.957% |
| NIOX Group Plc | 9.8 Million USD | 79.014% |
| Fuse Medical, Inc. | 15.11 Million USD | 86.386% |
| Broncus Holding Corporation | 10.43 Million USD | 80.282% |
| Brain Scientific Inc. | 7.42 Million USD | 72.301% |
| Pressure BioSciences, Inc. | 33.8 Million USD | 93.915% |
| Health Logic Interactive Inc. | 794.08 Thousand USD | -159.048% |